Author(s):
Aswathy SR, Hemnath Elango, Archana V, Arsha Surendran
Email(s):
hemnathelango@kahedu.edu.in
DOI:
10.52711/0974-360X.2025.00414 
Address:
Aswathy SR1*, Hemnath Elango2, Archana V3, Arsha Surendran4
1Research Scholar, Faculty of Pharmacy, Karpagam Academy of Higher Education, Pollachi Main Road, Eachanari Post, Coimbatore – 641021.
2Centre-Head, Faculty of Pharmacy, Karpagam Academy of Higher Education, Pollachi Main Road, Eachanari Post, Coimbatore – 641021.
3Research Scholar, Faculty of Pharmacy, Karpagam Academy of Higher Education, Pollachi Main Road, Eachanari Post, Coimbatore – 641021.
4Quality Control Analyst, Faculty of Pharmacy, Karpagam Academy of Higher Education, Pollachi Main Road, Eachanari Post, Coimbatore – 641021.
*Corresponding Author
Published In:
Volume - 18,
Issue - 6,
Year - 2025
ABSTRACT:
Cardiovascular disorders are most common in today’s era. One of the most important causes of cardiovascular diseases is hypercholesterolemia. In recent years develop a new and novel combination drug for the treatment of hypercholesterolemia has rosuvastatin and bempedoic acid. Rosuvastatin is a new generation fully synthetic HMG-CoA reductase inhibitor. Rosuvastatin's methane-sulphonamide group is polar, allowing it to have low lipophilicity and a stronger interaction with the 5-hydroxy-3-methylglutaryl-coenzyme A reductase enzyme. An increase in LDL-C reduction is associated with a greater reduction in cardiovascular events. A pro-drug bempedoic acid is an adenosine triphosphate-citrate (ATP) lyase inhibitor. Chemically, it is 8-hydroxy-2, 2, 14, 14-tetramethylpentadecanedioic acid. This review focuses on analytical techniques such as spectrophotometric, chromatographic, hyphenated, and electrochemical methods for the estimation of rosuvastatin and bempedoic acid alone or in combination with other drugs. This review gives information for future prospective studies for a researcher.
Cite this article:
Aswathy SR, Hemnath Elango, Archana V, Arsha Surendran. Investigation of Analytical Methods for the Estimation of Rosuvastatin and Bempedoic acid in Pharmaceutical Formulation and Human Plasma: A Review. Research Journal of Pharmacy and Technology. 2025;18(6):2875-3. doi: 10.52711/0974-360X.2025.00414
Cite(Electronic):
Aswathy SR, Hemnath Elango, Archana V, Arsha Surendran. Investigation of Analytical Methods for the Estimation of Rosuvastatin and Bempedoic acid in Pharmaceutical Formulation and Human Plasma: A Review. Research Journal of Pharmacy and Technology. 2025;18(6):2875-3. doi: 10.52711/0974-360X.2025.00414 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-6-67
REFERENCES:
1. Singh H, Gupta R D, Gautam G. Determination of Rosuvastatin Calcium in bulk and Pharmaceutical dosage forms by using UV-Spectrophotometric method. Asian Journal of Pharmacy and Pharmacology. 2018; 4(1): 45-48. DOI:10.31024/ajpp.2018.4.1.8
2. Luvai A, bagaya W Barth J H. Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease. Clinical Medicine Insights: Cardiology. 2012; 6: 17-33. DOI: 10.4137/CMC.S4324
3. Richard H Ho,Rommel GT etal. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology. 2006; 130(6): 1793-1806. doi: 10.1053/j.gastro.2006.02.034.
4. Hatch, G., Rosuvastatin. Current Opinion in Cardiovascular, Pulmonary and Renal Investigational Drugs. 2000; 2(3): 270-3.
5. Shiva G, Christopher N B etal. Effects of curcumin on HDL functionality. 2017; 119: 59. doi.org/10.1016/j.phrs.2017.02.008.
6. Uyar B, Celebier M, Altinoz S. Spectrophotometric determination of rosuvastatin calcium in tablets, Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2007; 62(6): 411-413.
7. Gupta A, Mishra P, Shah K. Simple UV spectrophotometric determination of rosuvastatin calcium in pure form and in pharmaceutical formulations. E-journal of Chemistry. 2009; 6(1): 89-92. doi.org/10.1155/2009/956712.
8. Ramadan AA. H. Mandil H, Alsayed-Ali R. Spectrophotometric determination of rosuvastatin in pure form and pharmaceutical formulations through ion-pair complex formation using bromocresol green. International Journal of Pharmaceutical Sciences. 2015; 7(11):191-198.
9. Prajapati P. Bodiwala K, et al. Development and validation of extractive spectrophotometric method for determination of rosuvastatin calcium in pharmaceutical dosage forms. Journal of Pharmarcy Research. 2010; 3(8): 2036-8.
10. Ramadan A A, Mandil H, Alshelhawi N. Spectrophotometric determination of rosuvastatin calcium in pure form and pharmaceutical formulations by the oxidation using iodine and formation triiodide complex in acetonitrile. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6(5): 579-585.
11. Lima M F, Cassella R J, Pacheco W F. Spectrophotometric determination of rosuvastatin in pharmaceutical formulations using quinalizarin. Brazilian Journal of Pharmaceutical Sciences. 2017; 53. doi.org/10.1590/s2175-97902017000300075
12. Tuljarani G, Gowri sankar etal. Visible spectrophotometric determination of rosuvastatin in bulk and pharmaceutical formulations. Oriental Journal of Chemistry. 2010; 26(2):589-593.
13. Sailaja B, Kumari K S. Analytical method development and validation for the estimation of rosuvastatin calcium in raw material and tablet formulation by UV spectrometric method. Saudi Journal Medical and Pharmaceutical Sciences. 2016;2(1):7-11. DOI: 10.36348/sjmps.2016.v02i01.002
14. Patil A, Meenaxi M et al. Green solvent assisted uv-spectrophotometric method for estimation of rosuvastatin in bulk and pharmaceutical dosage forms. Research Journal of Pharmacy and Technology. 2022; 15(2): 587-590. DOI: 10.52711/0974-360X.2022.00096
15. Gupta A, Mishra P, Shah K. Simple UV spectrophotometric determination of rosuvastatin calcium in pure form and in pharmaceutical formulations. E-Journal of Chemistry 2008; 6(1): 89-92. https://doi.org/10.1155/2009/956712
16. Rajkondwar V V, Maini P, Vishwakarma M. Characterization and method development for estimation and validation of Rosuvastatin Calcium by UV–visible spectrophotometry. International Journal of Theoretical and Applied Sciences. 2009; 1(1).
17. Funde A, Kokat J. A Validated Stability Indicating UV-Spectrophotometric Simultaneous Estimation Of Rosuvastatin Calcium And Fenofibrate In Bulk And Pharmaceutical Formulation. International Journal Of Chemistry Research. 2021; 5(1): 1-8. DOI: http://dx.doi.org/10.22159/ijcr.2021v5i1.144.
18. Shinde N G, Aloorkar N H. Development and validation of UV spectrophotometric method for simultaneous estimation of propranolol hydrochloride and rosuvastatin calcium in bulk drug and pharmaceutical dosage form. International Journal of Applied Pharmaceutics. 2015;4(5):55-59. DOI:10.7439/ijap
19. Baliram P S, Manish k, pravin G et al. Simultaneous estimation of rosuvastatin calcium and clopidogrel bisulphate by first order derivative UV spectrophotometric method. Invent Rapid:Pharmceutical Analysis and Quality Assurance. 2013;3:1-6.
20. Maha A H, Maryam A B, et al. Univariate and multivariate assisted spectrophotometric methods for determination of rosuvastatin calcium and fenofibrate in bulk powders and tablets along with their degradation products. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2021; 248: 119163. doi.org/10.1016/j.saa.2020.119163
21. Asma A, Tasnuva H et al. Spectrophotometric estimation of rosuvastatin calcium and glimepiride in tablet dosage form. Asian Journal of Pharmaceutical Analysis. 2011;1(4):74-78.
22. Bhavna P, Alpa J, heena S et al. Development and validation of derivative spectroscopic method for the simultaneous estimation of rosuvastatin calcium and fenofibrate in tablet. International Journal of Pharma Research and Review. 2013;2(7):1-6.
23. Parmar V, Solanki H, Prajapati L. Derivative spectrophotometric determination of rosuvastatin calcium and fenofibrate in tablet dosage form. Inventi Rapid: Pharm Analysis & Quality Assurance. 2013;2:1-5.
24. Anandkumar, Jayamaryapan M. Simultaneous estimation of rosuvastatin calcium and fenofibrate in bulk and in tablet dosage form by UV-spectrophotometry and RP-HPLC. Stamford Journal of Pharmaceutical Sciences. 2011; 4(1): 58-63. DOI:10.3329/sjps.v4i1.8868
25. Badawy A M, et al. Stability indicating spectrophotometric methods for determination of rosuvastatin in the presence of its acid degradation products by derivative spectrophotometric techniques. Journal of Advanced Pharmaceutical Research. 2011; 2(1):44-55.
26. Pramod NK, Ravindranath B S. Spectroscopic determination and validation of Rosuvastatin calcium concentration in Bulk and dosage form. 2016; 9(7): 761-763. doi: 10.5958/0974-360X.2016.00144.X
27. Elseena Jose, anjana C nair, Merlin K, Vishnu Govind A. Development and validation of a solvent extraction UV spectrophotometric method for the estimation of Rosuvastatin Calcium and telmisartan ij combined dosage form. Research Journal of Phrmacy and Technology. 2022;15(5):2065-2069. doi: 10.52711/0974-360X.2022.00341
28. Nagvenkar Pratiksha, Nazareth celina. Simultaneous analysis of ezetimibe and Rosuvastatin by Q absorption ratio method. Research Journal of Pharmacy and Technology. 2023; 16(9): 4276-4280. DOI: 10.52711/0974-360X.2023.00700
29. Rao A L, Suneetha D. Development and validation of RP-HPLC method for the estimation of rosuvastatin in bulk and pharmaceutical dosage form. International Journal of Chemical Science. 2010; 8(2): 1308-1314.
30. Kaila H O, Ambasana M A, et al. A new improved RP-HPLC method for assay of rosuvastatin calcium in tablets. Indian Journal of Pharmaceutical Sciences. 2010;72(5):592. doi: 10.4103/0250-474X.78526
31. Donthula S, Kumar M K, et al. A new validated RP-HPLC method for determination of Rosuvastatin calcium in bulk and Pharmaceutical Dosage Form. 2011;3(3):350-356.
32. Beludari, M.I., K.V. Prakash, and G.K. Mohan, RP-HPLC method for simultaneous estimation of rosuvastatin and ezetimibe from their combination tablet dosage form. International Journal of Chemical and Analytical Science, 2013. 4(4): p. 205-209.
33. Devika, G., M. Sudhakar, and J.V. Rao, A new improved RP-HPLC method for simultaneous estimation of rosuvastatin calcium and fenofibrate in tablets. International Journal of Pharmacy and Pharmaceutical Science. 2011;3(4):311-315.
34. Moussa B A, Hashem H et al. A validated RP-HPLC method for the determination of rosuvastatin in presence of sacubitril/valsartan in rat plasma: Application to in vivo evaluation of OATP-mediated drug interaction potential between rosuvastatin and sacubitril/valsartan. Microchemical Journal. 2018; 143: 31-38. doi.org/10.1016/j.microc.2018.07.021
35. Kumar T R, Shitut N R, Kumar P S, et al. Determination of rosuvastatin in rat plasma by HPLC: validation and its application to pharmacokinetic studies. Biomedical Chromatography. 2006;20(9):881-887. doi.org/10.1002/bmc.611
36. Ashfaq M, Ahmad H, et al. LC determination of rosuvastatin and ezetimibe in human plasma. Journal of the Chilean Chemical Society. 2013; 58(4): 2177-2181. doi.org/10.4067/S0717-97072013000400059
37. Sujatha P, Hanumantha Rao K, Venkateswara Rao B. A modified stability indicating liquid chromatographic method development and validation for the estimation of clopidigrel and Rosuvastatin in bulk and dosage forms. Research Journal of Pharmacy and Technology. 2020; 13(3): 1324-1328. doi: 10.5958/0974-360X.2020.00244.9
38. Trivedi H K, Patel M C. Development and validation of a stability-indicating RP-UPLC method for determination of rosuvastatin and related substances in pharmaceutical dosage form. Scientia Pharmaceutica. 2012; 80(2): 393-406. doi.org/10.3797/scipharm.1201-09
39. Paladugu Venkata Naveen, Seru Ganapaty.Development and validation of a new stability indicating ultra-fast liquid chromatographic (RP-UFLC) method for the quatification of Rosuvastatin. Research Journal of Pharmacy and Technology. 2021; 14(3): 1673-1679. doi: 10.5958/0974-360X.2021.00297.3
40. Siddartha B, Babu I S. Estimation and validation for determination of rosuvastatin in human plasma by LC/MS/MS method. Journal of Global Trends Pharmaceutical Sciences. 2014; 5(3): 1979-1988.
41. Kallem R R, Karthik A, et al. Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for quantification of rosuvastatin in small volume human plasma samples and its application to a clinical study. Arzneimittelforschung. 2007; 57(11): 705-711. doi.org/10.1055/s-0031-1296671
42. Elgawish M S, Soltan M K, Sebaiy M M. An LC–MS/MS spectrometry method for the simultaneous determination of rosuvastatin and irbesartan in rat plasma: Insight into pharmacokinetic and drug-drug interaction studies. Journal of Pharmaceutical and Biomedical Analysis. 2019; 174: 226-234. doi.org/10.1016/j.jpba.2019.05.069
43. Singh S S, Sharma K, et al. Estimation of rosuvastatin in human plasma by HLPC tandem mass spectroscopic method and its application to bioequivalence study. Journal of the Brazilian Chemical Society. 2005; 16: 944-950. doi.org/10.1590/S0103-50532005000600009
44. Trivedi R K, Kallem R R, Mullangi R, et al. Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC–MS/MS with electrospray ionization: assay development, validation and application to a clinical study. Journal of Pharmaceutical and Biomedical Analysis. 2005; 39(3-4): 661-669. doi: 10.1016/j.jpba.2005.05.005.
45. Moon S J, Lee S E, et al. Validation of LC-MS/MS method for determination of rosuvastatin concentration in human blood collected by volumetric absorptive microsampling (VAMS). Translational and Clinical Pharmacology. 2021; 29(3): 125. https://doi.org/10.12793/tcp.2021.29.e13
46. Silva T A, Zanin H, et al. Electrochemical determination of rosuvastatin calcium in pharmaceutical and human body fluid samples using a composite of vertically aligned carbon nanotubes and graphene oxide as the electrode material. Sensors and Actuators B: Chemical. 2015; 218: 51-59. doi.org/10.1016/j.snb.2015.04.085
47. Biolo G, Vinci P, Mangogna A, et al. Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome. Frontiers in Cardiovascular Medicine. 2022;9:1028355. https://doi.org/10.3389/fcvm.2022.1028355
48. National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 10472693, Bempedoic Acid. Retrieved November 6, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/Bempedoic-Acid.
49. Cicero AFG, Fogacci F, Hernandez AV, et al. Efficacy and safety of bemedoic acid for the treatment of hypercholesterolemia:A Systematic Review and Meta-Analysis. 2020; 17(7): 1003121. https://doi.org/10.1371/journal.pmed.1003121
50. Chaudhari, Mansi V, Ujwal, etal. Stability indicating method development and validation for the estimation of bempedoic acid by RP-HPLC. Drug Metabolism and Bioanalysis Letters. 2024; 17(1): 23-33. https://doi.org/10.2174/0118723128278080240404052506
51. Karla V R, Raghasudha M, et al. Simultaneous determination of bempedoic acid and ezetimibe in rat plasma using HPLC–PDA and its applications to a pharmacokinetic study. Chemistry Africa. 2022; 5(4): 917-927. doi.org/10.1007/s42250-022-00392-7
52. Maheshwari K, Rani S S. Validated method for the simultaneous estimation of bempedoic acid and ezetimibe in bulk and tablet formulation by RP-HPLC method. World Journal of Pharmaceutical Sciences. 2022; 10(9): 33-41. doi.org/10.54037/WJPS.2022.10090
53. Vejendla A, Talari S, Ramu G, et al. Characterization of novel stress degradation products of Bempedoic acid and Ezetimibe using UPLC–MS/MS: development and validation of stability-indicating UPLC method. Future Journal of Pharmaceutical Sciences. 2021;7:1-13. doi.org/10.1186/s43094-021-00381-6
54. Yarra U S T, Gummadi S, Stability indicating RP-UPLC method for simultaneous quantification of bempedoic acid and ezetimibe in bulk and pharmaceutical formulations. Future Journal of Pharmaceutical Sciences. 2021; 7: 1-9. doi.org/10.1186/s43094-021-00363-8
55. Dandamudi S, Rangapuram V. Synchronized analysis of bempedoic acid and ezetimibe in pure binary mixture and their combined tablets by a new stability indicating RP-UPLC method. International Journal of Health Sciences. 2021; (3): 7278-7290. https://doi.org/10.53730/ijhs.v6nS3.7743
56. Parthiban C, Anusha Reddy M, Sudhakar M. RP-HPLC method development and validation for the simultaneous estimation of Bempedoic acid and Ezetimibe in Pharmaceutical Dosage form. International Journal of Pharmacy and Pharmaceutical Research. Human. 2022; 26(1): 160-121
57. Vandana J, Daksha R, Shubham Nikam. Development and validation of Novel RP-HPLC method for the simultaneous estimation of Ezetimibe and Bempedoic acid in a tablet dosage form. International Journal of Pharmaceutical Sciences and Research. 2022; 13(11): 4680-4685. DOI: 10.13040/IJPSR.0975-8232.13(11).4680-85
58. Sai Datri A, nataraj K S, Rao L. Development and validation of novel analytical method for the simultaneous estimation of bempedoic acid and Ezetimibe in Bulk and Pharmaceutical dosage form by RP-UPLC. Journal of Drug and Alcohol Research. 2022; 11: 8. DOI:10.4303/jdar/236190
59. Fathima H B, Ayesha B K. A new validated RP-HPLC method for the analysis of Bempedoic acid and Ezetimibe in bulk drug samples. International Journal of Pharmacy and Analytical Research. 2020; 9(4): 248-252. https://doi.org/10.61096/ijpar.v9.iss4.2020.248-252
60. Divya M, Krishnamanjari P A, Sushma P. Stability indicating method development and validation for the estimation of Bempedoic acid and Ezetimibe by RP-UPLC. International Journal of Pharmaceutical Sciences and Drug Research. 2021; 13(5): 559-564. DOI: 10.25004/IJPSDR.2021.130514